Xuanying Wang

Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota.

Yong Guo, Qinghua Yao, Fan Zhang, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota

Yong Guo, Zewei Zhang, Qinghua Yao, 2022, BMC cancer.

The Modulation of Chaihu Shugan Formula on Microbiota Composition in the Simulator of the Human Intestinal Microbial Ecosystem Technology Platform and its Influence on Gut Barrier and Intestinal Immunity in Caco-2/THP1-Blue™ Cell Co-Culture Model

M. Marzorati, Ling Liu, L. Verstrepen, 2022, Frontiers in Pharmacology.

Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine

Yong Guo, Qinghua Yao, Haitao Chen, 2023, International journal of biological sciences.